Back to all papers

FZ-VLM: A Two Stage Florence-Zephyr Vision Language Model Framework for Pulmonary Nodule Characterization and Clinical Decision Making

August 15, 2026arxiv logopreprint

Authors

Pramit Dutta,Jenita Manokaran,Richa Mittal,Ryan Appleby,Eranga Ukwatta

Abstract

Lung cancer remains one of the leading causes of cancer-related mortality worldwide, and Computed Tomography (CT) is a primary imaging tool for screening and followup assessment. After pulmonary nodule detection, radiologists manually assess anatomical location, diameter, margin characteristics, and attenuation type to support risk assessment and clinical decision-making. However, this post-detection workflow is time-consuming and can be affected by inter-observer variability. Existing Artificial Intelligence methods often focus on isolated tasks, limiting their use as a unified, clinically grounded interpretation framework. This study presents FZ-VLM, a two-stage Florence-Zephyr Vision Language Model framework for unified structured pulmonary nodule characterization in lung CT. The framework uses a fine-tuned Florence-2 model to extract radiological attributes from expert-annotated 2D axial CT slices, while a Zephyr-7B model uses these attributes to generate nodule descriptions, follow-up recommendations, and longitudinal analyses. Results showed that the Stage 1 model achieved 77.18\% accuracy for anatomical location, 67.96\% accuracy for margin characteristics, and 79.13\% accuracy for attenuation type, with a Mean Absolute Error of 2.58 mm for diameter estimation, outperforming evaluated GPT-4-based baselines as well as the human baseline. Expert radiologist evaluation of Stage 2 showed 93.9\% accuracy, 98.6\% completeness score, 76.1\% clinical relevance, and an overall score of 89.5\%. Safety analysis showed that most outputs were clinically safe, although some follow-up recommendations still required expert review. To the best of our knowledge, this study presents the first two-stage Vision-Language Model framework for structured nodule characterization and clinical decision-making.

Topics

cs.CV

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.